Register now to learn about a new option for relapsed or refractory follicular lymphoma

Matthew Galsky on Treating Different Subsets of Bladder Cancer

MATTHEW GALSKY, MD
Wednesday, August 17, 2016


Matthew Galsky, MD, medical oncologist, Icahn School of Medicine at Mount Sinai, discusses treating different subsets of bladder cancer.

The most common type of bladder cancer, non muscle invasive, is highly curable with standard treatment. Cure still remains a possibility as the cancer spreads to the muscle later, though there is an increased chance of further spread. Then as the cancer spreads to regional lymph nodes and then becomes distant metastatic disease, the potential for cure decreases, but Galsky is hopeful that the developments of new targets will offer more options to these patients.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.